For the First Time, Ferring Reports Revenue of Over €2.5 Billion in 2025

Contributed by: Business Wire

Logo

Tags

Research

Genetics

Biotechnology

Other Health

Health

Pharmaceutical

Other Science

Science

Oncology

Ferring Pharmaceuticals

More Like This

Ferring achieved record sales driven by Reproductive Medicine combined with the emergence of Adstiladrin

Launch of two first-in-class medicines in 2023 marks start of exciting phase of growth for Ferring

Ferring Pharmaceuticals bolsters global gene therapy supply chain with European manufacturing facility

PR Newswire associated0

Servier delivers solid performance in 2024/25 and confirms its forecasts for 2030

Chiesi Group's 2023 Revenue Surpasses €3 Billion Mark, Reflecting 10% Growth Year-on-Year (+12% @CER), Underlining Commitment to Innovative, Sustainable Practices

Takeda Reports First Half FY2025 Results, with Business Fundamentals Tracking as Planned. Updates Full Year Outlook to Reflect FX Impact and Pipeline Impairment. On Track for Multiple Regulatory Filings This Fiscal Year

Lundbeck delivers 14% CER revenue growth, reflecting stronger momentum from Vyepti® and Rexulti® driven by additional investments

PR Newswire associated0

Endo Reports First-Quarter 2025 Financial Results and Reaffirms 2025 Financial Guidance